28 May| 2021
Prilenia to Present at Jefferies Virtual Healthcare Conference
[Naarden, NL, 28 May 2021] – Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders, today announced that Dr Michael R. Hayden, MD, PhD Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Friday, June 4, 2021 at 1:00 p.m. ET
Details on changes to presentation dates/times can be found on the Company's website. Please check www.prilenia.com for the latest information.
For further information, please contact:
Limor Ben Har, COO
Melanie Toyne-Sewell / Agnes Stephens
T: +44 (0) 207 457 2020